SUV39H2 Antibody

Catalog Number: ASB-OACA07037
Article Name: SUV39H2 Antibody
Biozol Catalog Number: ASB-OACA07037
Supplier Catalog Number: OACA07037
Alternative Catalog Number: ASB-OACA07037-100UL,ASB-OACA07037-50UL
Manufacturer: Aviva
Host: Rabbit
Category: Proteine/Peptide
Application: ELISA, IHC, WB
Species Reactivity: Human
Immunogen: Recombinant Human Histone-lysine N-methyltransferase SUV39H2 protein (201-410AA)
Conjugation: Unconjugated
Alternative Names: H3-K9-HMTase 2,histone H3-K9 methyltransferase 2,histone methyltransferase SUV39H2,histone-lysine N-methyltransferase SUV39H2,KMT1B,lysine N-methyltransferase 1B,su(var)3-9 homolog 2,suppressor of variegation 3-9 homolog 2.
Histone methyltransferase that specifically trimethylates Lys-9 of histone H3 using monomethylated H3 Lys-9 as substrate. H3 Lys-9 trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 Lys-9 trimethylation is also required to direct DNA methylation at pericentric repeats. SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as cell cycle regulation, transcriptional repression and regulation of telomere length. May participate in regulation of higher-order chromatin organization during spermatogenesis. Recruited by the large PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1, contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 Lys-9 trimethylation.
Clonality: Polyclonal
NCBI: 79723
Form: Liquid
Immunohistochemistry of paraffin-embedded human breast cancer at dilution 1:100
Immunohistochemistry of paraffin-embedded human paranephros at dilution 1:100
All lanes: Histone-lysine N-methyltransferase SUV39H2 antibody at 0.32ug/ml
Lane 1: HepG2 w